433412068	433412068	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
11613643	11613643	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2997604	2997604	CD	B-NP	O
|	|	CC	I-NP	O
3/20/2006	3/20/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/27/2006	3/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2006	10/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
SWARR	SWARR	NNP	B-NP	I-protein
,	,	,	O	O
BLAKE	BLAKE	NNP	B-NP	O
R	R	NNP	I-NP	O
648-45-71-7	648-45-71-7	CD	I-NP	O
Ma	Ma	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
11/5/06	11/5/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SWEEDEN	SWEEDEN	NNP	B-NP	O
,	,	,	O	O
JOHNATHON	JOHNATHON	NNP	B-NP	O
PERCY	PERCY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
At	At	IN	B-NP	O
12	12	CD	I-NP	O
noon	noon	NN	I-NP	O
.	.	.	O	O

LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
at	at	IN	B-PP	O
noon	noon	NN	B-NP	O
COLESTIPOL	COLESTIPOL	NN	I-NP	O
HYDROCHLORIDE	HYDROCHLORIDE	NN	I-NP	O
10	10	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
6PM	6PM	NN	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
fat	fat	JJ	I-NP	O
soluble	soluble	JJ	I-NP	O
vitamins	vitamin	NNS	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
INSULIN	INSULIN	NN	I-NP	B-protein
GLARGINE	GLARGINE	NN	I-NP	I-protein
14	14	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HUMALOG	HUMALOG	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
scale	scale	NN	I-NP	O
Low	Low	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
supplemental	supplemental	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
Call	Call	VBP	B-VP	O
HO	HO	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
350	350	CD	B-NP	O
Please	Please	NN	I-NP	O
give	give	VBP	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
standing	stand	VBG	B-VP	O
mealtime	mealtime	NN	B-NP	O
insulin	insulin	NN	I-NP	O
IMDUR	IMDUR	NN	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
hold	hold	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
dialysis	dialysis	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
noon	noon	NN	I-NP	O
,	,	,	O	O
unless	unless	IN	B-SBAR	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
KLOR-CON	KLOR-CON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
IMC	IMC	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
TOPROL	TOPROL	NN	I-NP	I-protein
XL	XL	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
METOPROLOL	METOPROLOL	NNP	I-NP	I-protein
SUCCINATE	SUCCINATE	NNP	I-NP	I-protein
EXTENDED	EXTENDED	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	B-NP	O
100	100	CD	B-NP	O
or	or	CC	O	O
hr	hr	NN	B-NP	O
<	<	JJR	B-NP	O
60	60	CD	I-NP	O
and	and	CC	O	O
notify	notify	VBP	B-VP	O
HO	HO	NN	B-NP	O
if	if	IN	B-SBAR	O
holding	hold	VBG	B-VP	O
Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
FLOMAX	FLOMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TAMSULOSIN	TAMSULOSIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
At	At	IN	B-NP	O
12	12	CD	I-NP	O
noon	noon	NN	I-NP	O
.	.	.	O	O

TORSEMIDE	TORSEMIDE	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
notify	notify	VBP	B-VP	O
HO	HO	NN	B-NP	O
if	if	IN	B-SBAR	O
holding	hold	VBG	B-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gram	gram	NN	I-NP	O
K	K	NN	I-NP	O
+	+	SYM	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
LH	LH	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
unit	unit	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
5/21	5/21	CD	B-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	B-protein
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ESRD	ESRD	NNP	I-NP	O
,	,	,	O	O
PVD	PVD	NNP	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
3MIs	3MI	NNS	I-NP	O
3vCABG	3vCABG	NN	I-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/5	4/5	CD	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
tunneled	tunnel	VBN	B-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
RIJ	RIJ	NN	B-NP	O
10/11	10/11	CD	I-NP	O
Hemodialysis	Hemodialysis	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
HD	HD	NN	B-NP	O
initiation	initiation	NN	I-NP	O
.	.	.	O	O

******	******	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54	54	CD	I-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
bl	bl	NN	I-NP	O
Cr	Cr	NN	I-NP	O
2.5	2.5	CD	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
to	to	TO	B-PP	O
MSCH	MSCH	NN	B-NP	B-protein
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
metolazone	metolazone	NN	B-NP	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
needed	need	VBN	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
weight	weight	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
presented	present	VBD	B-VP	O
to	to	TO	I-VP	O
ED	ED	VB	I-VP	O
with	with	IN	B-PP	O
Cr	Cr	NN	B-NP	B-protein
5.1	5.1	CD	I-NP	I-protein
and	and	CC	O	O
looking	look	VBG	B-VP	O
dehydrated	dehydrate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
resuscitated	resuscitate	VBN	B-VP	O
with	with	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
decreasing	decrease	VBG	B-VP	O
to	to	TO	B-PP	O
3.9	3.9	CD	B-NP	O
.	.	.	O	O

Metolazone	Metolazone	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
with	with	IN	B-PP	O
Cr	Cr	NN	B-NP	O
dec	dec	NN	I-NP	O
to	to	TO	B-PP	O
3.4	3.4	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
pt	pt	NN	B-NP	O
appeared	appear	VBD	B-VP	O
at	at	IN	B-PP	O
renal	renal	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
11/18	11/18	CD	B-NP	O
with	with	IN	B-PP	O
extreme	extreme	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
and	and	CC	I-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

+	+	SYM	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
sleeps	sleep	NNS	B-NP	O
in	in	IN	B-PP	O
chair	chair	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
any	any	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
or	or	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

BUN/Cr	BUN/Cr	NN	B-NP	O
102/3	102/3	CD	I-NP	O
.3	.3	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
14-french	14-french	JJ	B-NP	O
double	double	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
TC	TC	NN	I-NP	O
placement	placement	NN	I-NP	O
today	today	NN	B-NP	O
in	in	IN	B-PP	O
IR	IR	NN	B-NP	B-protein
.	.	.	O	O

Presently	Presently	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
soreness	soreness	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
R	R	NN	I-NP	B-DNA
tunnel	tunnel	NN	I-NP	I-DNA
catheter	catheter	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
CP	CP	NN	I-NP	B-DNA
but	but	CC	O	O
has	have	VBZ	B-VP	O
some	some	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Planned	Plan	VBN	B-VP	O
for	for	IN	B-PP	O
HD	HD	NN	B-NP	O
tomorrow	tomorrow	NN	I-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

******	******	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
3v	3v	CD	B-NP	O
CABG	CABG	NN	I-NP	O
1996	1996	CD	I-NP	O
;	;	:	O	O
PVD	PVD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
R	R	NN	I-NP	O
AKA	AKA	NN	I-NP	O
.	.	.	O	O

s/p	s/p	NN	B-NP	O
bilateral	bilateral	JJ	I-NP	O
femoral-popliteal	femoral-popliteal	JJ	I-NP	O
and	and	CC	I-NP	O
bypass	bypass	JJ	I-NP	O
graft	graft	NN	I-NP	O
;	;	:	O	O
DM	DM	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
x	x	CC	I-NP	O
44	44	CD	I-NP	O
yrs	yr	NNS	I-NP	O
,	,	,	O	O
c/b	c/b	NN	B-NP	O
diabetic	diabetic	JJ	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
retinopathy	retinopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetic	diabetic	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
;	;	:	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
lactose	lactose	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
Right	Right	NN	B-NP	O
hydronephrosis	hydronephrosis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
ureteral	ureteral	JJ	I-NP	O
stricture	stricture	NN	I-NP	O
.	.	.	O	O

Bilateral	Bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
******	******	SYM	B-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
penicillin	penicillin	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
******	******	SYM	I-NP	O
Medications	Medication	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
150	150	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
imdur	imdur	JJ	B-NP	O
ER	ER	NN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
zemplar	zemplar	JJ	B-NP	O
1mg	1mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
klorcon	klorcon	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
colestipol	colestipol	NN	B-NP	O
1g	1g	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
toprol-XL	toprol-XL	NN	B-NP	B-protein
50	50	CD	B-NP	I-protein
qhs	qh	NNS	I-NP	I-protein
,	,	,	O	O
lantus	lantus	NN	B-NP	O
14	14	CD	I-NP	O
unit	unit	NN	I-NP	O
sc	sc	NN	I-NP	O
,	,	,	O	O
humalog	humalog	NN	B-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
5mg	5mg	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

******	******	SYM	O	O
ADMISSION	ADMISSION	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	B-protein
T	T	NN	I-NP	I-protein
95.5	95.5	CD	I-NP	I-protein
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
64	64	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
100/56	100/56	CD	I-NP	I-DNA
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
18	18	CD	I-NP	I-protein
,	,	,	O	O
O2sat	O2sat	NN	B-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
sitting	sit	VBG	B-VP	O
at	at	IN	B-PP	O
45	45	CD	B-NP	O
degrees	degree	NNS	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	O
3mm	3mm	NN	I-NP	O
pupils	pupil	NNS	I-NP	O
.	.	.	O	O

Arcus	Arcus	NN	B-NP	O
senilus	senilus	NN	I-NP	O
.	.	.	O	O

EOMI	EOMI	LS	B-LST	B-DNA
.	.	.	O	O

O/p	O/p	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

Tenderness	Tenderness	NN	B-NP	O
at	at	IN	B-PP	O
R	R	NN	B-NP	O
tunnel	tunnel	NN	I-NP	O
cath	cath	NN	I-NP	O
site	site	NN	I-NP	O
o/w	o/w	NN	I-NP	O
dressing	dress	VBG	B-VP	O
c/d/i	c/d/i	NNS	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
bilateral	bilateral	JJ	B-NP	O
base	base	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
BS	BS	NN	I-NP	O
to	to	TO	B-PP	O
=	=	SYM	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
and	and	CC	O	O
widely	widely	RB	B-NP	O
split	split	JJ	I-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

3/6	3/6	CD	B-NP	O
harsh	harsh	JJ	I-NP	O
SEM	SEM	NN	I-NP	O
loudest	loud	JJS	B-ADJP	O
in	in	IN	B-PP	O
pulmonic	pulmonic	JJ	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
RV	RV	NN	B-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
>	>	SYM	I-NP	O
15cm	15cm	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
to	to	TO	B-VP	O
jaw	jaw	VB	I-VP	O
standing	stand	VBG	I-VP	O
up	up	RP	B-PRT	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Abd	Abd	NN	B-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
nontender	nontender	JJ	I-NP	O
+	+	SYM	I-NP	O
BS	BS	NNP	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ulcers	ulcer	NNS	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

0-1	0-1	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
AO	AO	NN	B-NP	B-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

CN2-12	CN2-12	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Motor	Motor	NN	B-NP	O
strength	strength	NN	I-NP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
except	except	IN	B-PP	O
decreased	decrease	VBN	B-VP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

******	******	SYM	O	O
LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
3/20	3/20	CD	B-NP	O
Na	Na	NN	I-NP	O
137	137	CD	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
3.3	3.3	NN	I-NP	I-cell_line
,	,	,	O	O
Cl	Cl	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
102	102	CD	I-NP	I-cell_line
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
3.3	3.3	CD	I-NP	O
,	,	,	O	O
Glc	Glc	NNP	B-NP	O
293	293	CD	I-NP	O
9/27	9/27	CD	I-NP	O
AST	AST	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
17	17	CD	I-NP	I-DNA
,	,	,	O	O
ALKP	ALKP	NN	B-NP	B-protein
118	118	CD	I-NP	I-protein
,	,	,	O	O
TB	TB	NN	B-NP	O
1.0	1.0	CD	I-NP	O
9/27	9/27	CD	I-NP	O
WBC	WBC	NNP	B-NP	O
7.4	7.4	CD	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	B-cell_line
34.3	34.3	CD	I-NP	I-cell_line
,	,	,	O	O
PLT	PLT	NNP	B-NP	O
211	211	CD	I-NP	O
1/10	1/10	CD	I-NP	O
PT	PT	NN	I-NP	O
14.4	14.4	CD	B-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
33.7	33.7	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	O
1.1	1.1	CD	I-NP	O
9/3/06	9/3/06	CD	I-NP	O
:	:	:	O	O
UA	UA	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

******	******	SYM	O	O
MAJOR	MAJOR	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
ECG	ECG	NN	B-NP	O
3/30/06	3/30/06	CD	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-DNA
68	68	CD	I-NP	I-DNA
,	,	,	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
biatrial	biatrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
QRS	QRS	NN	B-NP	B-DNA
196	196	CD	I-NP	I-DNA
,	,	,	O	O
BBB	BBB	NNP	B-NP	O
.	.	.	O	O

V4-V6	V4-V6	NN	B-NP	O
Q	Q	NN	I-NP	O
waves	wave	NNS	I-NP	O
and	and	CC	O	O
Tw	Tw	NN	B-NP	O
inv	inv	NN	I-NP	O
V5-V6	V5-V6	NN	I-NP	O
.	.	.	O	O

vs.	vs.	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
5/1	5/1	CD	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

PA/lateral	PA/lateral	JJ	B-NP	O
CXR	CXR	NN	I-NP	O
3/1/06	3/1/06	CD	I-NP	O
:	:	:	O	O
Interval	Interval	NN	B-NP	O
worsening	worsen	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Persistent	Persistent	JJ	B-NP	O
small	small	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

TTE	TTE	NN	B-NP	O
3/3	3/3	CD	I-NP	O
Overall	Overall	JJ	I-NP	O
LVEF	LVEF	NN	I-NP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Global	Global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
regional	regional	JJ	B-NP	O
variation	variation	NN	I-NP	O
.	.	.	O	O

Global	Global	JJ	B-NP	B-protein
RVSF	RVSF	NN	I-NP	I-protein
reduced	reduce	VBD	B-VP	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
.	.	.	O	O

RAE	RAE	NN	B-NP	B-protein
.	.	.	O	O

Trace	Trace	NNP	B-NP	O
AR	AR	NNP	I-NP	O
.	.	.	O	O

Mod	Mod	NNP	B-NP	O
MR.	MR.	NNP	I-NP	O
Mild	Mild	NNP	I-NP	O
-	-	HYPH	B-NP	O
mod	mod	NN	I-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

Mild	Mild	NNP	B-NP	O
PR	PR	NNP	I-NP	B-protein
.	.	.	O	O

********	********	SYM	O	O
HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54yo	54yo	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
CKD	CKD	NN	B-NP	B-protein
and	and	CC	O	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
2/2	2/2	CD	I-NP	O
diuresis	diuresis	NN	I-NP	O
limited	limit	VBN	B-VP	O
by	by	IN	B-PP	O
azotemia	azotemia	NN	B-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
tunnel	tunnel	NN	B-NP	O
catheter	catheter	NN	I-NP	O
placement	placement	NN	I-NP	O
and	and	CC	I-NP	O
initiation	initiation	NN	I-NP	O
of	of	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

*	*	SYM	O	O
Renal	Renal	JJ	O	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	I-VP	O
overloaded	overload	VBN	I-VP	O
by	by	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
TC	TC	NN	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
on	on	IN	B-PP	O
4/5	4/5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
first	first	JJ	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
on	on	IN	B-PP	O
10/11	10/11	CD	B-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
decreased	decrease	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
JVP	JVP	NN	B-NP	B-protein
,	,	,	O	O
less	less	JJR	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
held	hold	VBN	I-VP	O
zemplar	zemplar	NN	B-NP	O
and	and	CC	I-NP	O
metolazone	metolazone	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
told	tell	VBD	B-VP	O
pt	pt	NN	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	B-protein
medications	medication	NNS	I-NP	I-protein
otherwise	otherwise	RB	B-ADVP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
see	see	VB	B-VP	O
todo/plan	todo/plan	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
Monday	Monday	NNP	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
second	second	JJ	I-NP	O
dialysis	dialysis	NN	I-NP	O
run	run	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
Presently	Presently	RB	B-ADVP	O
,	,	,	O	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
formal	formal	JJ	B-NP	O
HCP	HCP	NN	I-NP	O
but	but	CC	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
arranging	arrange	VBG	B-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
.	.	.	O	O

*********	*********	SYM	O	O
Discharge	Discharge	NN	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-PP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
zemplar	zemplar	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
metolazone	metolazone	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
Torsemide	Torsemide	NN	B-NP	O
and	and	CC	I-NP	O
Klor-Con	Klor-Con	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
your	your	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
routine	routine	NN	I-NP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
Torsemide	Torsemide	NNP	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-PP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
zemplar	zemplar	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
metolazone	metolazone	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
Torsemide	Torsemide	NN	B-NP	O
and	and	CC	I-NP	O
Klor-Con	Klor-Con	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
your	your	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
routine	routine	NN	I-NP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
Torsemide	Torsemide	NNP	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
appointment	appointment	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
5/21	5/21	CD	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Lankewoo	Lankewoo	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
dialysis	dialysis	NN	I-NP	O
unit	unit	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CLACK	CLACK	NNP	B-NP	O
,	,	,	O	O
KERMIT	KERMIT	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IR38	IR38	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/5/06	11/5/06	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
26	26	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

